RxDoctor Payments Data

Michelle Vanoosten

Nurse Practitioner · Saint Helen, MINPI 1659616613

Payments from drug & device makers

$2,549in general payments, 2019–2025

Across 151 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$427
  • AstraZeneca$379
  • Lilly USA, LLC$363
  • Novartis$228
  • AbbVie$220
  • Pfizer$188
  • plus $744 from 16 others

What the payments were for

  • Food & beverage$2,547100%
  • Education$20%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,549 in reported general payments places this provider in the 90th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban99$141,283
TrulicityDulaglutide76$114,048
FarxigaDapagliflozin Propanediol70$97,846
JardianceEmpagliflozin77$91,025
OzempicSemaglutide42$82,079
Trelegy ElliptaFluticasone/Umeclidin/Vilanter75$73,979
Tresiba Flextouch U-200Insulin Degludec18$32,285
MounjaroTirzepatide22$29,529
XareltoRivaroxaban15$22,794
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog30$20,534
Soliqua 100-33Insulin Glargine/Lixisenatide12$11,715
Lantus SolostarInsulin Glargine,hum.Rec.Anlog60$8,825
Atorvastatin Calcium482$5,907
Lisinopril386$3,295
Levothyroxine Sodium268$3,186

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$363$143,57798 claims
PfizerEliquis$188$141,28399 claims
AstraZenecaFarxiga$379$97,84670 claims
Boehringer IngelheimJardiance$67$91,02577 claims
Novo NordiskOzempic$427$82,07942 claims
GSKTrelegy Ellipta$66$73,97975 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus$84$13,22023 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Saint Helen

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →